These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8811373)

  • 41. RP-HPLC analysis of flucloxacillin in human plasma: validation and application to a bioequivalence study.
    Zhou Q; Ruan Z; Yuan H; Jiang B; Xu D
    Pharmazie; 2007 Feb; 62(2):101-4. PubMed ID: 17341027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dicloxacillin absorption and elimination in children.
    Smith AL; Meeks CA; Koup JR; Opheim KE; Weber A; Vishwanathan CT
    Dev Pharmacol Ther; 1990; 14(1):35-44. PubMed ID: 2311479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral flucloxacillin in septicaemia.
    Gobbo O; Street A; Bury RW; Moulds RF
    Med J Aust; 1992 Oct; 157(8):575. PubMed ID: 1479999
    [No Abstract]   [Full Text] [Related]  

  • 44. How to calculate clearance of highly protein-bound drugs during continuous venovenous hemofiltration demonstrated with flucloxacillin.
    Meyer B; Ahmed el Gendy S; Delle Karth G; Locker GJ; Heinz G; Jaeger W; Thalhammer F
    Kidney Blood Press Res; 2003; 26(2):135-40. PubMed ID: 12771540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-vitro modelling of the bactericidal activity of teicoplanin versus flucloxacillin as used in surgical prophylaxis, against Staphylococcus aureus.
    Steer JA; Hill GB; Robbins MJ; Newton JC; Wilson AP
    J Antimicrob Chemother; 1997 Apr; 39(4):477-81. PubMed ID: 9145820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of flucloxacillin and cloxacillin in healthy subjects and patients on chronic intermittent haemodialysis.
    Nauta EH; Mattie H
    Br J Clin Pharmacol; 1975 Apr; 2(2):111-21. PubMed ID: 1234495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
    Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
    Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
    Ulldemolins M; Roberts JA; Wallis SC; Rello J; Lipman J
    J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic concentrations in serum and wound fluid after local gentamicin or intravenous dicloxacillin prophylaxis in cardiac surgery.
    Friberg O; Jones I; Sjöberg L; Söderquist B; Vikerfors T; Källman J
    Scand J Infect Dis; 2003; 35(4):251-4. PubMed ID: 12839154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigations on the flucloxacillin levels in human serum, lung tissue, pericardial fluid and heart tissue.
    Kiss IJ; Faragó E; Gömöry A; Szamaránszky J
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):405-11. PubMed ID: 7450932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The blood level of ampicillin and dicloxacillin alone or in association].
    Gooding PG; Fernandez CA; Perche de Menezes J; Ximenes J
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(5):168-72. PubMed ID: 5149954
    [No Abstract]   [Full Text] [Related]  

  • 52. Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin.
    Landersdorfer CB; Kirkpatrick CM; Kinzig-Schippers M; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3290-7. PubMed ID: 17576847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spectrophotometric determination of flucloxacillin and dicloxacillin in pure and dosage forms.
    El-Dien FA; Mohamed GG; Farag EY
    Spectrochim Acta A Mol Biomol Spectrosc; 2006 May; 64(1):210-5. PubMed ID: 16431153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of antibiotic protein binding on the killing rate of Staphylococcus aureus and on the paradoxical phenomenon.
    Odenholt I; Holm SE; Cars O
    Chemotherapy; 1987; 33(5):331-9. PubMed ID: 3665632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A simplified oral flucloxacillin absorption test for patients requiring long-term treatment.
    Dijkmans AC; Hartigh Jd; van Dissel JT; Burggraaf J
    Ther Drug Monit; 2012 Jun; 34(3):356-8. PubMed ID: 22569354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates.
    Pullen J; de Rozario L; Stolk LM; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Jun; 28(3):351-8. PubMed ID: 16778719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of dicloxacillin in rabbit muscle.
    Cars O; Ogren S; Erlendsdóttir H
    J Antimicrob Chemother; 1982 Mar; 9(3):201-7. PubMed ID: 7076603
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacology of some oral penicillins in the newborn infant.
    Cohen MD; Raeburn JA; Devine J; Kirkwood J; Elliott B; Cockburn F; Forfar JO
    Arch Dis Child; 1975 Mar; 50(3):230-4. PubMed ID: 1147656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein binding of flucloxacillin in neonates.
    Pullen J; Stolk LM; Degraeuwe PL; van Tiel FH; Neef C; Zimmermann LJ
    Ther Drug Monit; 2007 Jun; 29(3):279-83. PubMed ID: 17529883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunochemical detection of flucloxacillin adduct formation in livers of treated rats.
    Carey MA; van Pelt FN
    Toxicology; 2005 Dec; 216(1):41-8. PubMed ID: 16112790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.